To our knowledge, although many studies (approximately133) have been published on serum chemerin levels in patients with obesity or MS, a meta-analysis has not yet been performed aiming to integrate the findings of individual studies that investigated relationships between chemerin and various clinical indices in obesity or MS. The gene discussed is RARRES2; the disease is myeloid sarcoma.